ARTICLE IN ACADEMIC JOURNALS
NO | DETAILS OF ARTICLE IN ACADEMIC JOURNALS |
---|---|
1. |
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
2023
Author(s) : Chan Wah Kheong Source : CLINICS IN LIVER DISEASE DOI : 10.1016/j.cld.2023.01.019 |
2. |
Response to letter to editor: Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B
2023
Author(s) : Chan Wah Kheong Source : JOURNAL OF VIRAL HEPATITIS DOI : 10.1111/jvh.13858 |
3. |
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population
2023
Source : ANNALS OF HEPATOLOGY DOI : 10.1016/j.aohep.2022.100888 |
4. |
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease
2023
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : ALIMENTARY PHARMACOLOGY & THERAPEUTICS DOI : 10.1111/apt.17722 |
5. |
Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation and electronic reminder messages: a randomised controlled trial
2023
Author(s) : Chan Wah Kheong,Lim Lee Ling Source : GUT DOI : 10.1136/gutjnl-2023-330269 |
6. |
Is metabolic-dysfunction-associated fatty liver disease or advanced liver fibrosis associated with erythropoietin stimulating agent hypo-responsiveness among patients with end-stage kidney disease on haemodialysis?
2023
Author(s) : Lim Soo Kun,Chan Wah Kheong Source : NEPHROLOGY DOI : 10.1111/nep.14186 |
7. |
Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
2023
Source : HEPATOLOGY INTERNATIONAL DOI : 10.1007/s12072-023-10550-9 |
8. |
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH SIGNIFICANT IMPAIRMENT OF WORK PRODUCTIVITY: DATA FROM THE GLOBAL NASH REGISTRY™
2023
Author(s) : Chan Wah Kheong Source : HEPATOLOGY |
9. |
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
2023
Author(s) : Chan Wah Kheong Source : CHINESE MEDICAL JOURNAL DOI : 10.1097/CM9.0000000000002603 |
10. |
Frequency of significant steatosis and compensated advanced chronic liver disease among adults with chronic liver disease
2023
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.16313 |
11. |
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
2023
Author(s) : Chan Wah Kheong Source : JOURNAL OF VIRAL HEPATITIS DOI : 10.1111/jvh.13800 |
12. |
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
2023
Author(s) : Chan Wah Kheong,Chuah Kee Huat Source : CLINICAL AND MOLECULAR HEPATOLOGY DOI : 10.3350/cmh.2022.0426 |
13. |
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
2023
Author(s) : Chan Wah Kheong Source : HEPATOBILIARY SURGERY AND NUTRITION DOI : 10.21037/hbsn-22-421 |
14. |
Calculated parameters for the diagnosis of Wilson disease
2023
Author(s) : Pavai Sthaneshwar,Chan Wah Kheong Source : SINGAPORE MEDICAL JOURNAL DOI : 10.11622/smedj.2022019 |
15. |
Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
2023
Author(s) : Chan Wah Kheong Source : JOURNAL OF HEPATOLOGY DOI : 10.1016/j.jhep.2022.10.034 |
16. |
Comparison between obese and non-obese nonalcoholic fatty liver disease
2023
Author(s) : Chan Wah Kheong Source : CLINICAL AND MOLECULAR HEPATOLOGY DOI : 10.3350/cmh.2022.0350 |
17. |
Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP-Asia study
2023
Author(s) : Chan Wah Kheong Source : JOURNAL OF VIRAL HEPATITIS DOI : 10.1111/jvh.13796 |
18. |
Nonalcoholic Fatty Liver Disease A Unique Entity or Part of the Metabolic Syndrome or Both
2023
Author(s) : Chan Wah Kheong Source : MEDICAL CLINICS OF NORTH AMERICA DOI : 10.1016/j.mcna.2022.12.003 |
19. |
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
2023
Author(s) : Chan Wah Kheong Source : HEPATOLOGY INTERNATIONAL DOI : 10.1007/s12072-023-10543-8 |
20. |
Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
2023
Author(s) : Chan Wah Kheong Source : HEPATOBILIARY SURGERY AND NUTRITION DOI : 10.21037/hbsn-23-346 |
21. |
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
2022
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : WORLD JOURNAL OF GASTROENTEROLOGY DOI : 10.3748/wjg.v28.i15.1563 |
22. |
Epidemiological trends of gastrointestinal and liver diseases in Malaysia: A single-center observational study
2022
Author(s) : Sanjiv A/l K. Mahadeva,Ida Normiha Binti Hilmi,Chan Wah Kheong,Ho Shiaw Hooi,Chuah Kee Huat Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.15905 |
23. |
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry
2022
Author(s) : Chan Wah Kheong Source : JOURNAL OF VIRAL HEPATITIS DOI : 10.1111/jvh.13741 |
24. |
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
2022
Author(s) : Chan Wah Kheong Source : HEPATOLOGY COMMUNICATIONS DOI : 10.1002/hep4.2048 |
25. |
Metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiethnic urban population in Malaysia
2022
Author(s) : Lim Soo Kun,Chan Wah Kheong Source : SEMINARS IN DIALYSIS DOI : 10.1111/sdi.13117 |
26. |
A Global Survey of Physicians Knowledge About Nonalcoholic Fatty Liver Disease
2022
Author(s) : Chan Wah Kheong Source : CLINICAL GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1016/j.cgh.2021.06.048 |
27. |
Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems
2022
Author(s) : Chan Wah Kheong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.15843 |
28. |
Global multi-stakeholder endorsement of the MAFLD definition
2022
Source : LANCET GASTROENTEROLOGY & HEPATOLOGY DOI : 10.1016/S2468-1253(22)00062-0 |
29. |
Asian perspective on NAFLD-associated HCC
2022
Author(s) : Chan Wah Kheong Source : JOURNAL OF HEPATOLOGY DOI : 10.1016/j.jhep.2021.09.024 |
30. |
Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction-associated fatty liver disease
2022
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.15787 |
31. |
Meaning of non-overlapping patients between the MAFLD and NAFLD definitions
2022
Author(s) : Chan Wah Kheong Source : LIVER INTERNATIONAL DOI : 10.1111/liv.15142 |
32. |
Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients
2021
Author(s) : Chan Wah Kheong,Koh Peng Soon Source : The Medical journal of Malaysia |
33. |
Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
2021
Source : CLINICAL AND MOLECULAR HEPATOLOGY DOI : 10.3350/cmh.2020.0162 |
34. |
Nonalcoholic Fatty Liver Disease: A Global Perspective
2021
Author(s) : Chan Wah Kheong Source : CLINICAL THERAPEUTICS DOI : 10.1016/j.clinthera.2021.01.007 |
35. |
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial
2021
Author(s) : Chan Wah Kheong Source : LANCET GASTROENTEROLOGY & HEPATOLOGY DOI : 10.1016/S2468-1253(21)00031-5 |
36. |
Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for prediction of survival among Hepatocellular Carcinoma patients.
2021
Author(s) : Chan Wah Kheong,Koh Peng Soon Source : MEDICAL JOURNAL OF MALAYSIA |
37. |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
2021
Author(s) : Chan Wah Kheong Source : Gut DOI : 10.1136/gutjnl-2021-324243 |
38. |
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis
2021
Author(s) : Chan Wah Kheong Source : LANCET GASTROENTEROLOGY & HEPATOLOGY DOI : 10.1016/S2468-1253(20)30357-5 |
39. |
Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
2021
Author(s) : Chan Wah Kheong Source : Frontiers in Medicine DOI : 10.3389/fmed.2021.637652 |
40. |
Modest alcohol intake not associated with significant hepatic steatosis or more severe liver disease among patients with diabetes mellitus
2021
Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.15160 |
41. |
Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
2021
Author(s) : Chan Wah Kheong Source : FRONTIERS IN MEDICINE DOI : 10.3389/fmed.2021.637652 |
42. |
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
2021
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : ALIMENTARY PHARMACOLOGY & THERAPEUTICS DOI : 10.1111/apt.16487 |
43. |
Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease
2021
Source : PLOS ONE DOI : 10.1371/journal.pone.0250300 |
44. |
Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease
2021
Source : Plos One |
45. |
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
Author(s) : Chan Wah Kheong Source : BMC Gastroenterology DOI : 10.1186/s12876-020-01240-z. |
46. |
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B
2020
Author(s) : Rosmawati Binti Mohamed,Chan Wah Kheong Source : Journal of Viral Hepatitis DOI : 10.1111/jvh.13361 |
47. |
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : Hepatology International DOI : 10.1007/s12072-020-10094-2 |
48. |
The impact of chronic Hepatitis B on patient-reported outcomes from The Global Liver Registry™
2020
Author(s) : Chan Wah Kheong Source : Hepatology |
49. |
Liver stiffness measurement in non alcoholic fatty liver disease: two is better than one
2020
Author(s) : Sanjiv A/l K. Mahadeva,Shireene Ratna A/p D B Vethakkan,Chan Wah Kheong,Lai Lee Lee,Chuah Kee Huat Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.14978 |
50. |
Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial
2020
Author(s) : Chan Wah Kheong Source : Endoscopy DOI : 10.1055/a-1172-6027 |
51. |
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
2020
Author(s) : Chan Wah Kheong Source : Seminars in Liver Disease DOI : 10.1055/s-0040-1713006 |
52. |
Epidemiology of non-alcoholic fatty liver disease in Asia Indian Journal of Gastroenterology
2020
Source : Indian Journal of Gastroenterology |
53. |
Positive Hepatitis B core antibody is associated with cirrhosis and hepatocellular carcinoma in nonalcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : Am J Gastroenterol DOI : 10.14309/ajg.00(13)588 |
54. |
Significant knowledge gap about non-alcoholic fatty liver disease (NAFLD) in real-world practices: a global survey of hepatologists, gastroenterologists, endocrinologists and primary care physicians
2020
Author(s) : Chan Wah Kheong Source : Hepatology |
55. |
Unhealthy lifestyle habits and physical inactivity among Asian patients with non alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : Liver International DOI : 10.1111/liv.14638 |
56. |
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
2020
Author(s) : Chan Wah Kheong Source : The Lancet Gastroenterology & Hepatology DOI : 10.1016/S2468-1253(20)30190-4 |
57. |
A new definition for metabolic associated fatty liver disease :an international expert consensus statement
2020
Author(s) : Chan Wah Kheong Source : Journal of Hepatology DOI : 10.1016/j.jhep.2020.03.039 |
58. |
Allele HLA DQB1* 06 reduces fibrosis score in patients with non alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : Hepatology Research DOI : 10.1111/hepr.13525 |
59. |
Clinical and patient-reported outcomes data of non-alcoholic fatty liver disease: longitudinal data from the global NASH registry™
2020
Author(s) : Chan Wah Kheong Source : Hepatology |
60. |
Modest alcohol intake is not associated with significant hepatic steatosis nor more severe liver disease in patient with diabetes mellitus
2020
Author(s) : Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology |
61. |
Patient-reported outcomes in patients with chronic Hepatitis C: data from The Global Liver Registry
2020
Author(s) : Chan Wah Kheong Source : Hepatology |
62. |
Use of simple scoring systems for a public health approach in the management of non alcoholic fatty liver disease patients
2020
Author(s) : Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology Open DOI : 10.1002/jgh3.12414 |
63. |
Development and validation of a novel non-invasive test for diagnosing fibrotic NASH in patients with biopsy-proven NAFLD
2020
Author(s) : Chan Wah Kheong Source : J Gastroenterol Hepatol DOI : 10.1111/jgh.15055 |
64. |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020
Source : Lancet Gastroenterol Hepatol DOI : 10.1016/S2468-1253(19)30383-8 |
65. |
Liver stiffness measurement in non-alcoholic fatty liver disease: Two is better than one
2020
Author(s) : Sanjiv A/l K. Mahadeva,Shireene Ratna A/p D B Vethakkan,Chan Wah Kheong,Lai Lee Lee,Chuah Kee Huat Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.14978 |
66. |
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : HEPATOLOGY INTERNATIONAL DOI : 10.1007/s12072-020-10094-2 |
67. |
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease
2020
Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.14782 |
68. |
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
Author(s) : Goh Khean Lee,Chan Wah Kheong Source : BMC GASTROENTEROLOGY |
69. |
Volumetric Liver Fat Fraction Determines Grade of Steatosis More Accurately Than Controlled Attenuation Parameter in Patients With Nonalcoholic Fatty Liver Disease
2020
Author(s) : Yang Faridah Binti Abdul Aziz,Sanjiv A/l K. Mahadeva,Anushya A/p Vijayananthan,Kartini Binti Rahmat,Chan Wah Kheong,Lai Lee Lee Source : CLINICAL GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1016/j.cgh.2019.08.023 |
70. |
Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
2020
Source : DIGESTIVE DISEASES AND SCIENCES DOI : 10.1007/s10620-019-5477-1 |
71. |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020
Author(s) : Chan Wah Kheong Source : LANCET GASTROENTEROLOGY & HEPATOLOGY DOI : 10.1016/S2468-1253(19)30383-8 |
72. |
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
2020
Author(s) : Chan Wah Kheong Source : BMC GASTROENTEROLOGY DOI : 10.1186/s12876-020-01240-z |
73. |
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
2020
Author(s) : Chan Wah Kheong Source : JOURNAL OF HEPATOLOGY DOI : 10.1016/j.jhep.2020.03.039 |
74. |
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
2020
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : AMERICAN JOURNAL OF GASTROENTEROLOGY DOI : 10.14309/ajg.0000000000000588 |
75. |
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
76. |
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
2020
Author(s) : Chan Wah Kheong Source : LANCET GASTROENTEROLOGY HEPATOLOGY |
77. |
Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
2020
Author(s) : Chan Wah Kheong Source : WORLD JOURNAL OF GASTROENTEROLOGY DOI : 10.3748/wjg.v26.i19.2416 |
78. |
Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
2020
Author(s) : Chan Wah Kheong Source : LANCET GASTROENTEROLOGY & HEPATOLOGY DOI : 10.1016/S2468-1253(20)30190-4 |
79. |
Allele HLA-DQB1*06 reduces fibrosis score in patients with non-alcoholic fatty liver disease
2020
Author(s) : Rosmawati Binti Mohamed,Zahurin Binti Mohamed,Sanjiv A/l K. Mahadeva,Roma Choudhury Basu,Chan Wah Kheong,Shamsul Bin Mohd Zain,Eng Hooi Sian Source : HEPATOLOGY RESEARCH DOI : 10.1111/hepr.13525 |
80. |
Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial
2020
Author(s) : Chan Wah Kheong Source : ENDOSCOPY DOI : 10.1055/a-1172-6027 |
81. |
Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.15055 |
82. |
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease
2020
Author(s) : Chan Wah Kheong Source : LIVER INTERNATIONAL DOI : 10.1111/liv.14638 |
83. |
Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B
2020
Author(s) : Rosmawati Binti Mohamed,Chan Wah Kheong Source : JOURNAL OF VIRAL HEPATITIS DOI : 10.1111/jvh.13361 |
84. |
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future
2020
Author(s) : Chan Wah Kheong Source : SEMINARS IN LIVER DISEASE DOI : 10.1055/s-0040-1713006 |
85. |
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in non-alcoholic fatty liver disease
2020
Author(s) : Sanjiv A/l K. Mahadeva,Anushya A/p Vijayananthan,Kartini Binti Rahmat,Chan Wah Kheong,Lai Lee Lee,Leong Wai Ling Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY DOI : 10.1111/jgh.14782 |
86. |
Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
2020
Source : DIGESTIVE DISEASES AND SCIENCES |
87. |
MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong Source : Liver International |
88. |
A new bile acid treatment for non-alcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source : Lancet Gastroenterology and Hepatology |
89. |
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis.
2019
Author(s) : Chan Wah Kheong Source : Clinical Gastroenterology and Hepatology |
90. |
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease.
2019
Author(s) : Chan Wah Kheong Source : Gut |
91. |
Volumetric liver fat fraction determines grade of steatosis more accurately than controlled attenuation parameter in patients with nonalcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source : Clinical Gastroenterology and Hepatology DOI : https://doi.org/10.1016/j.cgh.2019.08.023 |
92. |
Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
2019
Author(s) : Shireene Ratna A/p D B Vethakkan,Chan Wah Kheong Source : Digestive Diseases and Sciences |
93. |
Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong Source : Liver International |
94. |
Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology |
95. |
Quantification of Liver Fat in NAFLD: Available Modalities and Clinical Significance
2019
Author(s) : Chan Wah Kheong,Chuah Kee Huat Source : Current Hepatology Reports DOI : 10.1007/s11901-019-00493-x |
96. |
Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis
2019
Author(s) : Pavai Sthaneshwar,Chan Wah Kheong Source : JGH Open |
97. |
Epidemiological differences of common liver conditions between Asia and the West
2019
Author(s) : Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology DOI : 10.1002/jgh3.12275 |
98. |
Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease
2019
Author(s) : Chan Wah Kheong Source : Clinical Gastroenterology and Hepatology DOI : https://doi.org/10.1016/j.cgh.2019.09.027 |
99. |
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients With Advanced Fibrosis
2019
Author(s) : Goh Khean Lee,Chan Wah Kheong Source : CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
100. |
Comparing point shear wave elastography (ElastPQ) and transient elastography for diagnosis of fibrosis stage in nonalcoholic fatty liver disease.
2019
Author(s) : Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology |
101. |
Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community
2018
Author(s) : Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology Open DOI : 10.1002/jgh3.12114 |
102. |
Endoscopic Management of Colonoscopy‑related Perforation
2018
Author(s) : Chan Wah Kheong Source : Journal of Digestive Endoscopy DOI : 10.4103/jde.JDE_74_17 |
103. |
Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease.
2018
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : Hepatology International DOI : https://doi.org/10.1007/s12072-018-9843-4 |
104. |
Screening for non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography
2018
Author(s) : Shireene Ratna A/p D B Vethakkan,Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology DOI : 10.1111/jgh.14577 |
105. |
Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
2018
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : Journal of Gastroenterology and Hepatology |
106. |
Clinical features and treatment of non-alcoholic fatty liver disease across the Asia Pacific region – the GO ASIA initiative
2018
Author(s) : Chan Wah Kheong Source : Alimentary Pharmacology and Therapeutics |
107. |
Hepatitis B virus infection among children of hepatitis B surface
antigen positive mothers in a Malaysian hospital.
2018
Author(s) : Chan Wah Kheong Source : Medical Journal of Malaysia |
108. |
Impact of Controlled Attenuation Parameter on Detecting Fibrosis using Liver Stiffness Measurement
2018
Author(s) : Chan Wah Kheong Source : Alimentary Pharmacology and Therapuetics |
109. |
Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
2018
Author(s) : Chan Wah Kheong Source : JGH Open |
110. |
Editorial: NAFLD in Asia – clinical associations with advanced disease become clearer – Authors’ reply.
2018
Author(s) : Chan Wah Kheong Source : Alimentary Pharmacology & Therapeutics |
111. |
Controlled attenuation parameter using Fibroscan XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population.
2017
Author(s) : Chan Wah Kheong Source : United European Gastroenterology Journal DOI : 10.1177/2050640616646528 |
112. |
Endoscopic sleeve gastroplasty: case report, technique and literature review.
2017
Author(s) : Chan Wah Kheong Source : Journal of Digestive Diseases |
113. |
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease
2017
Source : PLOS ONE DOI : 10.1371/journal.pone.0174982 |
114. |
Individual Patient Data Meta-Analysis of Controlled Attenuation Parameter (CAP) Technology for Assessing Steatosis.
2017
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : J Hepatol DOI : 10.1016/j.jhep.2016.12.022. |
115. |
Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease.
2017
Author(s) : Chan Wah Kheong Source : Hepatobiliary Surgery and Nutrition DOI : 10.21037/hbsn.2017.03.06 |
116. |
The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups.
2017
Author(s) : Chan Wah Kheong Source : J Gastroenterol Hepatol |
117. |
The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.
2017
Author(s) : Chan Wah Kheong Source : J Gastroenterol Hepatol |
118. |
A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.
2017
Author(s) : Sanjiv A/l K. Mahadeva,Chan Wah Kheong Source : Clin Gastroenterol Hepatol DOI : 10.1016/j.cgh.2017.04.016. |
119. |
Oxidized low-density lipoprotein in non-alcoholic steatohepatitis.
2016
Author(s) : Chan Wah Kheong Source : J Gastroenterol Hepatol DOI : 10.1111/jgh.13381 |
120. |
Asian Consensus on the Relationship between Obesity and Gastrointestinal and Liver Diseases.
2016
Author(s) : Chan Wah Kheong Source : J Gastroenterol Hepatol DOI : 10.1111/jgh.13385 |
121. |
Enteropathy-associated T-cell lymphoma: An extremely rare cause of chronic diarrhoea.
2016
Author(s) : Chan Wah Kheong,Koh Peng Soon Source : Medical Journal of Malaysia |
122. |
Split-dose low volume bowel preparation, a feasible option for preparation for colonoscopy.
2016
Author(s) : Chan Wah Kheong Source : Endoscopy |
123. |
A novel 2-step approach combining the NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis
2015
Author(s) : Chan Wah Kheong Source : Hepatology International |
124. |
Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy.
2015
Author(s) : Chan Wah Kheong Source : Journal of Digestive Diseases |
125. |
Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non- alcoholic fatty liver disease.
2015
Author(s) : Chan Wah Kheong Source : Scientific Reports |
126. |
Low physical activity and energy dense Malaysian foods are associated with non- alcoholic fatty liver dis-ease in centrally obese but not in non-centrally obese patients with diabetes mellitus
2015
Author(s) : Chan Wah Kheong Source : Asia Pac J Clin Nutr |
127. |
Narrow-band imaging and white-light endoscopy with optical magnification in the diagnosis of dysplasia in Barrett s esophagus: results of the Asia-Pacific Barrett s Consortium
2015
Author(s) : Chan Wah Kheong Source : Endoscopy International Open |
128. |
Split-dose vs same-day reduced-volume polyethylene glycol electrolyte lavage solution for morning colonoscopy
2014
Author(s) : Chan Wah Kheong Source : World Journal of Gastroenterology |
129. |
Progression of non-alcoholic fatty liver disease a prospective clinicopathological follow-up study
2014
Author(s) : Chan Wah Kheong Source : Journal of Digestive Diseases |
130. |
Limited utility of plasma M30 in discriminating non-alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2014
Author(s) : Chan Wah Kheong Source : Plos One |
131. |
Ultrasonography-diagnosed non-alcoholic fatty liver disease is not associated with prevalent ischemic heart disease among diabetics in a multiracial Asian hospital clinic population.
2014
Author(s) : Chan Wah Kheong Source : Clinics and Research in Hepatology and Gastroenterology |
132. |
Controlled attenuation parameter for detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
133. |
Genome-wide analysis of copy number variation identifies candidate gene loci associated with the progression of non-alcoholic fatty liver disease
2014
Author(s) : Rosmawati Binti Mohamed,Cheah Phaik Leng,Zahurin Binti Mohamed,Sanjay Rampal A/l Lekhraj Rampal,Chan Wah Kheong,Shamsul Mohd Zain Source : PLOS ONE |
134. |
Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.
2014
Author(s) : Chan Wah Kheong Source : Hepatology International |
135. |
Clinical outcomes and direct costing of endoluminal clipping compared to surgery in the management of iatrogenic colonic perforation.
2013
Source : Journal of Digestive Diseases DOI : 10.1111/1751-2980.12097 |
136. |
Non-Alcoholic Fatty Liver Disease (NAFLD) in Diabetics Prevalence and Predictive Factors in a Multi-Racial Hospital Clinic Population in Malaysia
2013
Author(s) : Chan Wah Kheong Source : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
137. |
Epidemiology of a Fast-Emerging Disease in the Asia Pacific Region - Non-Alcoholic Fatty Liver Disease (NAFLD).
2013
Author(s) : Chan Wah Kheong Source : Hepatology International |
138. |
Evaluation of patient satisfaction of an outpatient
gastroscopy service in an Asian tertiary care hospital.
2012
Author(s) : Chan Wah Kheong Source : BMC Gastroenterology |
139. |
Commentary: changing aetiology of peptic ulcers.
2012
Author(s) : Chan Wah Kheong Source : Alimentary Pharmacology and Therapeutics |
140. |
Cyclosporine Rescue Therapy in Autoimmune Liver
Cirrhosis: A Case Report.
2012
Author(s) : Chan Wah Kheong Source : Turkish Journal of Gastroenterology |
141. |
Evaluation of Patient Satisfaction of an Outpatient
Colonoscopy Service in an Asian Tertiary Care
Hospital.
2012
Author(s) : Chan Wah Kheong |
142. |
Appointment waiting times and education level
influence the quality of bowel preparation in
adult patients undergoing colonoscopy.
2011
Author(s) : Chan Wah Kheong Source : BMC Gastroenterology |
143. |
A validation study of the Leeds Dyspepsia
Questionnaire
in a multi-ethnic Asian population.
2011
Author(s) : Chan Wah Kheong Source : J Gastroenterol Hepatol |
144. |
Epidemiology of Helicobacter pylori Infection and
Public Health Implications
2011
Author(s) : Chan Wah Kheong Source : Helicobacter |
CHAPTER IN BOOK
NO | DETAILS OF CHAPTER IN BOOK |
---|
PROCEEDING
NO | DETAILS OF PROCEEDING |
---|---|
1. |
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease
2021
Author(s) : Chan Wah Kheong |
2. |
The Impact of COVID-19 Pandemic on Patients with Chronic Liver Disease (CLD): Data from the Global Registry
2021
Author(s) : Chan Wah Kheong |
3. |
The spectrum of gastrointestinal and liver diseases has an ethnic predilection: observations from a specialist clinic in Malaysia
2021
Author(s) : Chan Wah Kheong |
4. |
Individual patient data meta-analysis of the diagnostic performance of single and sequentially combined non-invasive tests in detecting advanced fibrosis
2021
Author(s) : Chan Wah Kheong |
5. |
Concordance between Fibroscan and aspartate aminotransferase-to-platelet ratio index (APRI) using different cut-off values in 603 Asian adults with chronic hepatitis C virus (HCV) with no or compensated cirrhosis in Thailand and Malaysia.
2021
Author(s) : Chan Wah Kheong |
6. |
Development and validation of Agile 3+: novel FibroScan based score for the diagnosis of advanced fibrosis in patients with nonalcoholic fatty liver disease
2021
Author(s) : Chan Wah Kheong |
7. |
Metabolic-dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis among hemodialysis patients in a multiracial urban population in Malaysia.
2021
Author(s) : Chan Wah Kheong |
8. |
Concordance between FibroScan® and Aspartate aminotransferase-to-Platelet Ratio Index (APRI) using different cut-off values in 301 Asian adults with chronic HCV with no or compensated cirrhosis in Thailand and Malaysia
2020
Author(s) : Chan Wah Kheong |
9. |
Prescription of Statin and Low-Density Lipoprotein Cholestrol Treatment Targets in Non-Alcoholic Fatty Liver Disease Petients
2019
Author(s) : Chan Wah Kheong |
10. |
Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients.
2019
Author(s) : Chan Wah Kheong |
11. |
Fibroscan as a Non-Invasive Approach to Predict the Presence and Size of Varices in the Malaysian Cirrhotic Population
2019
Author(s) : Chan Wah Kheong |
12. |
Liver Stiffness Measurement in Non-Alcoholic Fatty Liver Disease: Two is Better than One
2019
Author(s) : Chan Wah Kheong |
13. |
Non-Invasive Scoring Systems for the Diagnosis of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) in a Malaysian Cahort
2019
Author(s) : Chan Wah Kheong |
14. |
MACK-3 (Combination of HOMA, AST, CK18): A promising novel biomarker for fibrotic non-alcoholic steatohepatitis
2019
Author(s) : Chan Wah Kheong |
15. |
Screening for Non-alcoholic Fatty Liver Disease and Advance Liver Fibrosis in Patients with Type 2 Diabetes Mellitus Using Controlled Attenuation Parameter and Liver Stiffness Measurements
2018
Author(s) : Chan Wah Kheong |
16. |
Safety and efficacy of ravidasvir plus sofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients with hepatitis C virus genotype 1,2,3,and 6 The STORM-C-1 phase IIIII trial
2018
Author(s) : Chan Wah Kheong |
17. |
Comparing Shear Wave Elastography and Transient Elastography for the Diagnosis of Fibrosis Stages in Patients with Non-alcoholic Fatty Liver Disease Using Liver Biopsy as the Reference Standard
2018
Author(s) : Chan Wah Kheong |
18. |
Comparison of HepaFat-Scan and controlled attenuation parameter for the estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease using histology as the reference standard
2018
Author(s) : Chan Wah Kheong |
19. |
Macroscopic On-site Quality Evaluation (MOSE) of Biopsy Specimens to Improve The Diagnostic Accuracy During EUS-Guided FNA Using a 19G Needle for Solid Lesions: A Prospective Randomized Controlled Study.
2018
Author(s) : Chan Wah Kheong |
20. |
Empagliflozin for the treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes Mellitus
2018
Author(s) : Chan Wah Kheong |
21. |
Current Therapies - What Has Promise? What Does Not?
2018
Author(s) : Chan Wah Kheong |
22. |
Direct Acting Anti-Viral (DAA) in Hepatitis C Virus (HCV) Patients: Early Real-World Data From Malaysia.
2018
Author(s) : Chan Wah Kheong |
23. |
A pilot study of empagliflozin for the treatment of non-alcoholic steatohepatitis in patients with type 2 diabetes mellitus
2018
Author(s) : Chan Wah Kheong |
24. |
A non-invasive biomarker of hepatic inflammation based on magnetic resonance imaging. Journal of Hepatology
2018
Author(s) : Chan Wah Kheong |
25. |
A Comparison of the Hepafat-Scan and Fibroscan Controlled Attenuation Parameter in the Estimation of Hepatic Steatosis in Patients with Nonalcoholic Fatty Liver Disease Using Histology as the Reference Standard
2018
Author(s) : Chan Wah Kheong |
26. |
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein as a serum biomarker for disease severity in nonalcoholic fatty liver disease
2017
Author(s) : Chan Wah Kheong |
27. |
The high prevalence and predictors of advance fibrosis in elderly patients with liver biopsy confirmed non-alcoholic fatty liver disease (NAFLD)-The GOASIA STUDY.
2017
Author(s) : Chan Wah Kheong |
28. |
Perception and bariatric practices of obesity-related gastrointestinal (GI) disease among Asian GI practitioners: GOASIA working group initiative
2017
Author(s) : Chan Wah Kheong |
29. |
Comparing the BCLC and HKLC staging systems in the management of hepatocellular carcinoma in a tertiary center in Malaysia
2017
Author(s) : Chan Wah Kheong |
30. |
Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan )?
2017
Author(s) : Chan Wah Kheong |
31. |
Do same cut-off values for controlled attenuation parameter (CAP) apply for both M probe and Xl probe of transient elastography (FibroScan®)?
2017
Author(s) : Chan Wah Kheong |
32. |
A Substantial Proportion of Patients with Chronic Hepatitis B have Significant Fibrosis and Concomitant Fatty Liver: Results from a Cross-Sectional Study Using FibroScan at Major Tertiary Hospital in Malaysia
2017
Author(s) : Chan Wah Kheong |
33. |
Outcomes of Biopsy-Proven Non-Alcoholic Fatty Liver Disease (NAFLD) in South East Asian Patients: A Single Tertiary Center Experience
2017
Author(s) : Chan Wah Kheong |
34. |
Management of NAFLD – case discussion
2017
Author(s) : Chan Wah Kheong |
35. |
Non-alcoholic fatty liver disease- demographic features, risk factors and treatment practices across the Asia Pacific region-the GOASIA initiative
2017
Author(s) : Chan Wah Kheong |
36. |
Non-alcoholic fatty liver disease demographic features, risk factors and treatment practices across the Asia Pacific region the GO ASIA initiative
2017
Author(s) : Chan Wah Kheong |
37. |
A Study of Non-Alcoholic Fatty Liver Disease Using Trasient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-Aged Malaysian Cohort
2016
Author(s) : Chan Wah Kheong |
38. |
Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Ballooning and Adult NAFLD Patients: Non-invansive Biomarkers in Diagnosis of Non-Alcoholic Steatohapetitis (NASH) in Adult Patients
2016
Author(s) : Chan Wah Kheong |
39. |
Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study
2016
Author(s) : Chan Wah Kheong |
40. |
New Therapeutic Options for NAFLD
2016
Author(s) : Chan Wah Kheong |
41. |
Is Silymarin Useful for the Treatment of Non- Alcoholic Fatty Liver Disease?: A Meta Analysis
2016
Author(s) : Chan Wah Kheong |
42. |
A Study on Transmission of Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers from A tertiary Hospital in Malaysia
2016
Author(s) : Chan Wah Kheong |
43. |
An Asian Multicentre Study On Biopsy-Proven NAFLD Patients-Part of The GO ASIA Initiative
2016
Author(s) : Chan Wah Kheong |
44. |
Serum Aspartate Aminotransferase Levels As A Predictor of Histological Improvement in Patients with Non-Alcoholic Steatohepatitis : Results from A Randomized, Double- Blinded, Placebo- Controlled Study
2016
Author(s) : Chan Wah Kheong |
45. |
Hepatitis B Virus Infection Among Children of Hepatitis B Surface Antigen Positive Mothers In A Tertiary Hospital In Malaysia
2016
Author(s) : Chan Wah Kheong |
46. |
Silymarin Improves Fibrosis In Non-Alcoholic Steatohepatitis
2016
Author(s) : Chan Wah Kheong |
47. |
Serum Cathepsin D and Cytokeratin-18 Levels for Lobular Inflammation and Balloning in Adult NAFLD Patients: Non Invalsive Biomarkers in Diagnosis of Non Alcoholic Steatohapetitis (NASH) In Adult patients
2016
Author(s) : Chan Wah Kheong |
48. |
A Study of Non-Alcoholic Fatty Liver Disease Using Transient Elastography and Carotid Intima Media Thickness Using Ultrasonography in a Middle-aged Malaysian Population
2016
Author(s) : Chan Wah Kheong |
49. |
A randomized double-blind, placebo-controlled trial of silymarin for the treatment of non-alcoholic steatohepatitis
2016
Author(s) : Chan Wah Kheong |
50. |
Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease?
2015
Author(s) : Chan Wah Kheong |
51. |
Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2015
Author(s) : Chan Wah Kheong |
52. |
Is controlled attenuation parameter with the XL probe more accurate than the M probe for estimation of hepatic steatosis in patients with non-alcoholic fatty liver disease?
2015
Author(s) : Chan Wah Kheong |
53. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
54. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
55. |
A novel 2 step approach combining the nafld fibrosis score and liver stiffness measurement for predicting advanced fibrosis
2015
Author(s) : Chan Wah Kheong |
56. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
57. |
Silymarin for the treatment of non-alcoholic steatohepatitis: interim analysis of a randomized, double-blind, placebo-controlled trial.
2015
Author(s) : Chan Wah Kheong |
58. |
Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
59. |
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
60. |
Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non- alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
61. |
Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2014
Author(s) : Chan Wah Kheong |
62. |
Combination of NAFLD fibrosis score and liver stiffness measurement for predicting advanced fibrosis in non-alcoholic fatty liver disease.
2014
Author(s) : Chan Wah Kheong |
63. |
Limited utility of plasma M30 in discriminating non- alcoholic steatohepatitis from steatosis - a comparison with routine biochemical markers.
2014
Author(s) : Chan Wah Kheong |
64. |
Ultrasonography-diagnosed non-alcoholic fatty liver disease (NAFLD) is not associated with prevalent ischemic heart disease (IHD) among long-standing poorly controlled diabetics.
2013
Author(s) : Chan Wah Kheong |
65. |
Ultrasonography-diagnosed NAFLD is not associated with IHD among long-standing poorly-controlled diabetics
2013
Author(s) : Chan Wah Kheong |
66. |
Prevalence of NAFLD and associated factors among multi- racial Malaysian population.
2013
Author(s) : Chan Wah Kheong |
67. |
Reduced-volume PEG-ELS plus bisacodyl split- dose is better than same morning whole-dose for morning outpatient colonoscopy: result of an investigator- and endoscopist-blinded, randomized study
2013
Author(s) : Chan Wah Kheong |
68. |
Split versus whole-dose PEG-ELS for bowel preparation in outpatient colonoscopy.
2013
Author(s) : Chan Wah Kheong |
69. |
Non-alcoholic fatty liver disease in young adults � worrying ethnic differences in a multi-racial Asian population in Malaysia
2013
Author(s) : Chan Wah Kheong |
70. |
Low physical activity and high percentage calorie intake from fat, high cholesterol food and high saturated fatty acid food is associated with NAFLD in centrally obese diabetics
2013
Author(s) : Chan Wah Kheong |
71. |
Progression of non-alcoholic fatty liver disease (NAFLD) � a prospective clinicopathological follow-up study
2013
Author(s) : Chan Wah Kheong |
72. |
Clinical and histological follow-up of a cohort of patients with NAFLD.
2012
Author(s) : Chan Wah Kheong |
73. |
Prevalence of NAFLD among diabetic patients in the outpatient clinic of a Malaysian hospital and associated factors.
2012
Author(s) : Chan Wah Kheong |
74. |
Endoluminal clipping versus surgery in the management of iatrogenic colonic perforation: a direct cost analysis.
2012
Author(s) : Chan Wah Kheong |
75. |
The role of diet and physical activity in non-alcoholic fatty liver disease (NAFLD) in diabetic patients.
2012
Author(s) : Chan Wah Kheong |
76. |
Patient satisfaction of outpatient gastroscopy in University of Malaya Medical Centre endoscopy unit.
2011
Author(s) : Chan Wah Kheong |
77. |
Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital.
2011
Author(s) : Chan Wah Kheong |
78. |
Iatrogenic colonic perforations during colonoscopy: incidence, management and outcome in a Malaysian tertiary hospital.
2011
Author(s) : Chan Wah Kheong |
79. |
Patient satisfaction of outpatient gastroscopy in University Malaya Medical Centre endoscopy unit.
2011
Author(s) : Chan Wah Kheong |
80. |
Risk factors for poor bowel preparation and its impact on technical performance and patient. comfort in an Asian population
2010
Author(s) : Chan Wah Kheong |
81. |
Patient satisfaction with various aspects of an outpatient colonoscopy service.
2010
Author(s) : Chan Wah Kheong |
RESEARCH COLLABORATOR
GRANT | PROGRESS | STATUS |
---|